{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:53:02Z","timestamp":1792414382946,"version":"4.4.0"},"reference-count":104,"publisher":"American Medical Association (AMA)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,4,5]]},"DOI":"10.1001\/jama.2022.3880","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:02:17Z","timestamp":1649156537000},"page":"1269","source":"Crossref","is-referenced-by-count":448,"title":["Antiseizure Medications for Adults With Epilepsy"],"prefix":"10.1001","volume":"327","author":[{"given":"Andres M.","family":"Kanner","sequence":"first","affiliation":[{"name":"Comprehensive Epilepsy Center and Epilepsy Division, Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Melo","family":"Bicchi","sequence":"additional","affiliation":[{"name":"Comprehensive Epilepsy Center and Epilepsy Division, Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"jrv220006r1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/epi.2005.46.issue-4","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"issue":"4","key":"jrv220006r2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy.","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"16","key":"jrv220006r3","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1212\/WNL.0000000000001487","article-title":"Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.","volume":"84","author":"Krumholz","year":"2015","journal-title":"Neurology"},{"issue":"10","key":"jrv220006r4","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/epi.2006.47.issue-10","article-title":"Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization.","volume":"47","author":"Theodore","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"jrv220006r5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy.","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"3","key":"jrv220006r6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies.","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"jrv220006r7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/STROKEAHA.111.000220","article-title":"Incidence and associations of poststroke epilepsy: the prospective South London Stroke Register.","volume":"44","author":"Graham","year":"2013","journal-title":"Stroke"},{"issue":"5","key":"jrv220006r8","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1212\/WNL.51.5.1256","article-title":"Is the underlying cause of epilepsy a major prognostic factor for recurrence?","volume":"51","author":"Semah","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"jrv220006r9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.2017.58.issue-4","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology.","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"5","key":"jrv220006r10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jamaneurol.2019.4785","article-title":"Assessment of the predictive value of outpatient smartphone videos for diagnosis of epileptic seizures.","volume":"77","author":"Tatum","year":"2020","journal-title":"JAMA Neurol"},{"issue":"9","key":"jrv220006r11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3109\/00207454.2013.785543","article-title":"Latency to the first epileptiform activity in the EEG of epileptic patients.","volume":"123","author":"Badry","year":"2013","journal-title":"Int J Neurosci"},{"issue":"3","key":"jrv220006r12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.eplepsyres.2011.03.008","article-title":"Understanding juvenile myoclonic epilepsy: contributions from neuroimaging.","volume":"94","author":"Anderson","year":"2011","journal-title":"Epilepsy Res"},{"issue":"3","key":"jrv220006r13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/2013.jamaneurol.337","article-title":"Hospital-onset seizures: an inpatient study.","volume":"70","author":"Fields","year":"2013","journal-title":"JAMA Neurol"},{"issue":"5","key":"jrv220006r14","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/epi.2009.50.issue-5","article-title":"Is a first acute symptomatic seizure epilepsy? mortality and risk for recurrent seizure.","volume":"50","author":"Hesdorffer","year":"2009","journal-title":"Epilepsia"},{"issue":"4","key":"jrv220006r15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1474-4422(06)70383-0","article-title":"Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial.","volume":"5","author":"Kim","year":"2006","journal-title":"Lancet Neurol"},{"issue":"12","key":"jrv220006r16","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/epi.2012.53.issue-12","article-title":"The prognosis of idiopathic generalized epilepsy.","volume":"53","author":"Seneviratne","year":"2012","journal-title":"Epilepsia"},{"issue":"4","key":"jrv220006r17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/epi.1997.38.issue-4","article-title":"Patients\u2019 experiences of injury as a result of epilepsy.","volume":"38","author":"Buck","year":"1997","journal-title":"Epilepsia"},{"issue":"1","key":"jrv220006r18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/epi.1998.39.issue-1","article-title":"Long-term survival of people with unprovoked seizures: a population-based study.","volume":"39","author":"Olafsson","year":"1998","journal-title":"Epilepsia"},{"issue":"10","key":"jrv220006r19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/epi.1999.40.issue-10","article-title":"Short-term mortality after a first epileptic seizure: a population-based study.","volume":"40","author":"Loiseau","year":"1999","journal-title":"Epilepsia"},{"issue":"10","key":"jrv220006r20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S1474-4422(16)30158-2","article-title":"Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention.","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"issue":"2","key":"jrv220006r21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/WCO.0000000000000177","article-title":"Seizure clusters: characteristics and treatment.","volume":"28","author":"Haut","year":"2015","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"jrv220006r22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ana.v87.1","article-title":"Therapeutic drug monitoring of newer antiepileptic drugs: a randomized trial for dosage adjustment.","volume":"87","author":"A\u00edcua-Rap\u00fan","year":"2020","journal-title":"Ann Neurol"},{"issue":"5","key":"jrv220006r23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy.","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"jrv220006r24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study.","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"},{"key":"jrv220006r25","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107993","article-title":"Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: a guide for clinicians.","volume":"120","author":"Gidal","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"6","key":"jrv220006r26","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/epi.2010.51.issue-6","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"3","key":"jrv220006r27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1017\/S109285291600002X","article-title":"Nonepileptic seizures: an updated review.","volume":"21","author":"Perez","year":"2016","journal-title":"CNS Spectr"},{"key":"jrv220006r28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.seizure.2016.08.005","article-title":"Frequency of a false positive diagnosis of epilepsy: a systematic review of observational studies.","volume":"41","author":"Xu","year":"2016","journal-title":"Seizure"},{"issue":"7","key":"jrv220006r29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.seizure.2005.08.008","article-title":"Epilepsy in the UK: misdiagnosis, mistreatment, and undertreatment? the Wrexham area epilepsy project.","volume":"14","author":"Leach","year":"2005","journal-title":"Seizure"},{"issue":"8","key":"jrv220006r30","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","article-title":"Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"jrv220006r31","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1212\/01.WNL.0000123695.22623.32","article-title":"Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"jrv220006r32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5698\/1535-7597.18.4.260","article-title":"Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.","volume":"18","author":"Kanner","year":"2018","journal-title":"Epilepsy Curr"},{"issue":"4","key":"jrv220006r33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5698\/1535-7597.18.4.269","article-title":"Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: treatment-resistant epilepsy: report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.","volume":"18","author":"Kanner","year":"2018","journal-title":"Epilepsy Curr"},{"issue":"7","key":"jrv220006r35","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/epi.2006.47.issue-7","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"issue":"11","key":"jrv220006r36","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJM199209103271104","article-title":"A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults: the Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.","volume":"327","author":"Mattson","year":"1992","journal-title":"N Engl J Med"},{"issue":"3","key":"jrv220006r37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.","volume":"313","author":"Mattson","year":"1985","journal-title":"N Engl J Med"},{"issue":"4","key":"jrv220006r38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1055\/s-2008-1063985","article-title":"Selection of drugs for the treatment of epilepsy.","volume":"10","author":"Mattson","year":"1990","journal-title":"Semin Neurol"},{"issue":"1","key":"jrv220006r39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0920-1211(89)90070-3","article-title":"A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy.","volume":"3","author":"Dam","year":"1989","journal-title":"Epilepsy Res"},{"issue":"8948","key":"jrv220006r40","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy.","volume":"345","author":"Brodie","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"jrv220006r41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0920-1211(96)01013-3","article-title":"A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy.","volume":"26","author":"Christe","year":"1997","journal-title":"Epilepsy Res"},{"issue":"3","key":"jrv220006r42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0920-1211(97)00025-9","article-title":"A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy.","volume":"27","author":"Guerreiro","year":"1997","journal-title":"Epilepsy Res"},{"issue":"3","key":"jrv220006r43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0920-1211(97)00024-7","article-title":"A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy.","volume":"27","author":"Bill","year":"1997","journal-title":"Epilepsy Res"},{"issue":"5","key":"jrv220006r44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/epi.1999.40.issue-5","article-title":"Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.","volume":"40","author":"Steiner","year":"1999","journal-title":"Epilepsia"},{"issue":"1","key":"jrv220006r45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0920-1211(99)00039-X","article-title":"Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy.","volume":"37","author":"Brodie","year":"1999","journal-title":"Epilepsy Res"},{"issue":"9","key":"jrv220006r46","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1046\/j.1528-1157.2002.45401.x","article-title":"Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.","volume":"43","author":"Brodie","year":"2002","journal-title":"Epilepsia"},{"issue":"6","key":"jrv220006r47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"jrv220006r48","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1474-4422(11)70154-5","article-title":"Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.","volume":"10","author":"Kwan","year":"2011","journal-title":"Lancet Neurol"},{"issue":"7","key":"jrv220006r49","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S1474-4422(12)70105-9","article-title":"Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.","volume":"11","author":"Baulac","year":"2012","journal-title":"Lancet Neurol"},{"issue":"10","key":"jrv220006r50","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/epi.2014.55.issue-10","article-title":"Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.","volume":"55","author":"Baulac","year":"2014","journal-title":"Epilepsia"},{"issue":"1","key":"jrv220006r51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1474-4422(16)30292-7","article-title":"Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.","volume":"16","author":"Baulac","year":"2017","journal-title":"Lancet Neurol"},{"issue":"9566","key":"jrv220006r52","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"10282","key":"jrv220006r53","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(21)00247-6","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet"},{"issue":"9566","key":"jrv220006r54","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"10282","key":"jrv220006r55","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(21)00246-4","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"jrv220006r56","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/epi.2009.50.issue-5","article-title":"Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society.","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"issue":"1","key":"jrv220006r57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/ane.2019.139.issue-1","article-title":"Antiepileptic monotherapy in newly diagnosed focal epilepsy: anetwork meta-analysis.","volume":"139","author":"Lattanzi","year":"2019","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"jrv220006r58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/epi.1998.39.issue-1","article-title":"Antiepileptic drugs as a cause of worsening seizures.","volume":"39","author":"Perucca","year":"1998","journal-title":"Epilepsia"},{"issue":"1","key":"jrv220006r59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40263-016-0398-4","article-title":"New non-intravenous routes for benzodiazepines in epilepsy: a clinician perspective.","volume":"31","author":"Mula","year":"2017","journal-title":"CNS Drugs"},{"issue":"5","key":"jrv220006r60","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/01.wnl.0000341789.77291.8d","article-title":"Assessment of potential drug interactions in patients with epilepsy: impact of age and sex.","volume":"72","author":"Gidal","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"jrv220006r61","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/bcp.2006.61.issue-3","article-title":"Clinically relevant drug interactions with antiepileptic drugs.","volume":"61","author":"Perucca","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"jrv220006r62","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/epi.2004.45.issue-7","article-title":"Hyponatremia due to an additive effect of carbamazepine and thiazide diuretics.","volume":"45","author":"Ranta","year":"2004","journal-title":"Epilepsia"},{"issue":"12","key":"jrv220006r63","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis.","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia"},{"issue":"2","key":"jrv220006r64","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy.","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"jrv220006r65","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1528-1167.2007.01262.x","article-title":"Are psychiatric adverse events of antiepileptic drugs a unique entity? a study on topiramate and levetiracetam.","volume":"48","author":"Mula","year":"2007","journal-title":"Epilepsia"},{"issue":"17","key":"jrv220006r66","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"key":"jrv220006r67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1528-1167.2007.01402.x","article-title":"Weight issues for people with epilepsy\u2014a review.","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"issue":"1-2","key":"jrv220006r68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2013.05.005","article-title":"Bone disease during chronic antiepileptic drug therapy: general versus specific risk factors.","volume":"331","author":"Beerhorst","year":"2013","journal-title":"J Neurol Sci"},{"issue":"4","key":"jrv220006r69","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1359\/jbmr.091027","article-title":"Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women\u2019s health initiative (WHI).","volume":"25","author":"Carbone","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"9","key":"jrv220006r70","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","article-title":"Effect of antiepileptic drugs on bone density in ambulatory patients.","volume":"58","author":"Farhat","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"jrv220006r71","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein.","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann Neurol"},{"issue":"5","key":"jrv220006r72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.seizure.2014.02.007","article-title":"Patients with epilepsy are at an increased risk of subsequent stroke: a population-based cohort study.","volume":"23","author":"Chang","year":"2014","journal-title":"Seizure"},{"issue":"11","key":"jrv220006r73","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2021.3424","article-title":"Association of enzyme-inducing antiseizure drug use with long-term cardiovascular disease.","volume":"78","author":"Josephson","year":"2021","journal-title":"JAMA Neurol"},{"issue":"7","key":"jrv220006r74","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1111\/epi.v62.7","article-title":"Epilepsy, antiepileptic drugs, and the risk of major cardiovascular events.","volume":"62","author":"Lee-Lane","year":"2021","journal-title":"Epilepsia"},{"issue":"2","key":"jrv220006r75","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1535759719835672","article-title":"Making rash decisions in epilepsy: evaluating hypersensitivity reactions to anti-seizure medications.","volume":"19","author":"Bermeo-Ovalle","year":"2019","journal-title":"Epilepsy Curr"},{"issue":"2","key":"jrv220006r76","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/epi.2006.47.issue-2","article-title":"Predictors of Lamotrigine-associated rash.","volume":"47","author":"Hirsch","year":"2006","journal-title":"Epilepsia"},{"issue":"7","key":"jrv220006r77","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.","volume":"64","author":"Mockenhaupt","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"jrv220006r78","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/epi.2007.48.issue-5","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"issue":"2","key":"jrv220006r79","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","article-title":"Practice parameter update: management issues for women with epilepsy\u2014focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"jrv220006r80","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1212\/WNL.0b013e3181a6b325","article-title":"Practice parameter update: management issues for women with epilepsy\u2014focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"jrv220006r81","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jamaneurol.2018.0646","article-title":"Fertility and birth outcomes in women with epilepsy seeking pregnancy.","volume":"75","author":"Pennell","year":"2018","journal-title":"JAMA Neurol"},{"issue":"7","key":"jrv220006r82","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"issue":"21","key":"jrv220006r83","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy.","volume":"78","author":"Hern\u00e1ndez-D\u00edaz","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"jrv220006r84","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1474-4422(12)70103-5","article-title":"Teratogenic effects of antiepileptic drugs.","volume":"11","author":"Tomson","year":"2012","journal-title":"Lancet Neurol"},{"issue":"3","key":"jrv220006r85","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"issue":"24","key":"jrv220006r86","doi-asserted-by":"publisher","first-page":"e3232","DOI":"10.1212\/WNL.0000000000010993","article-title":"Antiseizure medication use during pregnancy and risk of ASD and ADHD in children.","volume":"95","author":"Wiggs","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"jrv220006r87","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"9","key":"jrv220006r88","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.","volume":"85","author":"Campbell","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"jrv220006r89","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/epi.2009.50.issue-5","article-title":"Management issues for women with epilepsy\u2014ocus on pregnancy (an evidence-based review): III. vitamin K, folic acid, blood levels, and breast-feeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society.","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"issue":"4","key":"jrv220006r90","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s13311-016-0464-0","article-title":"Use of antiepileptic drugs during pregnancy: evolving concepts.","volume":"13","author":"Pennell","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"11","key":"jrv220006r91","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2013.4290","article-title":"Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy.","volume":"70","author":"Veiby","year":"2013","journal-title":"JAMA Neurol"},{"issue":"8751","key":"jrv220006r92","first-page":"1175","article-title":"Randomised study of antiepileptic drug withdrawal in patients in remission.","volume":"337","author":"Medical Research Council Antiepileptic Drug Withdrawal Study Group","year":"1991","journal-title":"Lancet"},{"issue":"1","key":"jrv220006r93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.72.1.22","article-title":"Discontinuing antiepileptic drugs in patients who are seizure free on monotherapy.","volume":"72","author":"Specchio","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"jrv220006r94","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1474-4422(17)30114-X","article-title":"Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis.","volume":"16","author":"Lamberink","year":"2017","journal-title":"Lancet Neurol"},{"issue":"4","key":"jrv220006r95","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1212\/WNL.44.4.601","article-title":"Relapse following discontinuation of antiepileptic drugs: a meta-analysis.","volume":"44","author":"Berg","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"jrv220006r96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.epilep.2012.07.001","article-title":"When and how to stop antiepileptic drugs.","volume":"1","author":"Beghi","year":"2013","journal-title":"Epileptology"},{"issue":"1-2","key":"jrv220006r97","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.yebeh.2010.02.014","article-title":"Idiopathic generalized epilepsy with generalized tonic-clonic seizures (IGE-GTC): a population-based cohort with >20 year follow up for medical and social outcome.","volume":"18","author":"Camfield","year":"2010","journal-title":"Epilepsy Behav"},{"issue":"24","key":"jrv220006r98","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1212\/01.wnl.0000437303.36064.f8","article-title":"Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors.","volume":"81","author":"Senf","year":"2013","journal-title":"Neurology"},{"issue":"12","key":"jrv220006r99","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/epi.1995.36.issue-12","article-title":"Absence epilepsies.","volume":"36","author":"Loiseau","year":"1995","journal-title":"Epilepsia"},{"issue":"10","key":"jrv220006r100","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00415-004-0521-1","article-title":"Long-term prognosis for childhood and juvenile absence epilepsy.","volume":"251","author":"Trinka","year":"2004","journal-title":"J Neurol"},{"issue":"3","key":"jrv220006r101","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1001\/jama.2014.17426","article-title":"Resective epilepsy surgery for drug-resistant focal epilepsy: a review.","volume":"313","author":"Jobst","year":"2015","journal-title":"JAMA"},{"issue":"Pt 5","key":"jrv220006r102","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/brain\/awh449","article-title":"Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis.","volume":"128","author":"T\u00e9llez-Zenteno","year":"2005","journal-title":"Brain"},{"key":"jrv220006r103","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/epi.2017.58.issue-S1","article-title":"Vagus nerve stimulation: surgical technique of implantation and revision and related morbidity.","volume":"58","author":"Giordano","year":"2017","journal-title":"Epilepsia"},{"issue":"6","key":"jrv220006r104","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3171\/2011.7.JNS11977","article-title":"Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response.","volume":"115","author":"Englot","year":"2011","journal-title":"J Neurosurg"},{"key":"jrv220006r34","year":"2021"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2790629\/jama_kanner_2022_rv_220006_1648650446.59983.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T12:24:32Z","timestamp":1700396672000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2790629"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":104,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,4,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.3880","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,5]]}}}